Pre-existing insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Pages (from-to)1-452
Number of pages452
JournalDiabetologia
Volume57
Publication statusPublished - 2014
Event50th EASD Annual Meeting - Vienna, Austria
Duration: 15 Sep 201419 Sep 2014

Keywords

  • type 1 diabetes

Cite this